Dr. Rand Paul’s Legislation to Lower Drug Prices Unanimously Advances Out of Committee
wasteful and repetitive clinical requirements that create unjustified barriers, further delaying competition in the market. Biopharmaceutical researchers have
Full-text search across every press release in the archive. Matches the title and body, with English stemming, “vote” catches “voted” and “voting.”
13 results for “barriers” · Senate · Kentucky
wasteful and repetitive clinical requirements that create unjustified barriers, further delaying competition in the market. Biopharmaceutical researchers have
regulations, such as reduced competition and prohibitive barriers to entry for would-be entrepreneurs. These costs are then … REINS Act earlier this year to remove barriers to economic growth for all Kentuckians. It’s time
judicial relief. Dr. Paul’s legislation removes those barriers, as well as the current immunity shield for COVID
already know that when Washington throws up artificial barriers, building and buying here at home become more expensive
already know that when Washington throws up artificial barriers, building and buying here at home become more expensive
governor, Martha Layne Collins was known for breaking barriers. Governor Collins was a tireless advocate for all levels
sort the bluster from the truth. “New trade barriers imposed this year have made it harder to sustain … board as the true costs of trade barriers fall inevitably on them. “Protectionists eagerly celebrate the revenue from
patients. Repealing it will remove an unnecessary legal barrier and bring transparency and competition back to the prescription
with Congress to eliminate this outdated and unnecessary barrier to lower-priced biosimilar medicines.” Background: “Biosimilars” – generic alternatives
Deregulation Actrestores market freedom by removing arbitrary barriers to innovation, expanding consumer access to affordable fuel options
wasteful and repetitive clinical requirementsthat create unjustified barriers, further delaying competition in the market. For years, biopharmaceutical researchers
deem unhealthy, restoring local control and removing federal barriers to innovation in public health policy. With nearly
Kentucky’s children, and our bill eliminates unnecessary barriers that have stood in the way of new, supportive